Exact Mass: 610.2539704000001

Exact Mass Matches: 610.2539704000001

Found 16 metabolites which its exact mass value is equals to given mass value 610.2539704000001, within given mass tolerance error 5.12E-10 dalton. Try search metabolite list with more accurate mass tolerance error 1.024E-10 dalton.

Candesartan cilexetil

1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid

C33H34N6O6 (610.2539704000001)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].

   

Gly Trp Trp Tyr

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Gly Trp Tyr Trp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Gly Tyr Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Gly Trp Tyr

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Gly Tyr Trp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Trp Gly Tyr

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Trp Tyr Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C33H34N6O6 (610.2539704000001)


   

Trp Tyr Gly Trp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Tyr Trp Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C33H34N6O6 (610.2539704000001)


   

Tyr Gly Trp Trp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Tyr Trp Gly Trp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Tyr Trp Trp Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C33H34N6O6 (610.2539704000001)


   

2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil

2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil

C33H34N6O6 (610.2539704000001)


   

2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil

2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil

C33H34N6O6 (610.2539704000001)


   

Candesartan cilexetil

Candesartan cilexetil

C33H34N6O6 (610.2539704000001)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].